These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
311 related items for PubMed ID: 12401599
1. Ondansetron and dolasetron provide equivalent postoperative vomiting control after ambulatory tonsillectomy in dexamethasone-pretreated children. Sukhani R, Pappas AL, Lurie J, Hotaling AJ, Park A, Fluder E. Anesth Analg; 2002 Nov; 95(5):1230-5, table of contents. PubMed ID: 12401599 [Abstract] [Full Text] [Related]
2. A comparison of the costs and efficacy of ondansetron versus dolasetron for antiemetic prophylaxis. Zarate E, Watcha MF, White PF, Klein KW, Sa Rego M, Stewart DG. Anesth Analg; 2000 Jun; 90(6):1352-8. PubMed ID: 10825320 [Abstract] [Full Text] [Related]
3. Dolasetron versus ondansetron for the treatment of postoperative nausea and vomiting. Meyer TA, Roberson CR, Rajab MH, Davis J, McLeskey CH. Anesth Analg; 2005 Feb; 100(2):373-377. PubMed ID: 15673860 [Abstract] [Full Text] [Related]
4. Comparison of oral dolasetron and ondansetron in the prophylaxis of postoperative nausea and vomiting in children. Karamanlioglu B, Turan A, Memis D, Süt N. Eur J Anaesthesiol; 2003 Oct; 20(10):831-5. PubMed ID: 14580054 [Abstract] [Full Text] [Related]
5. The effect of timing of dolasetron administration on its efficacy as a prophylactic antiemetic in the ambulatory setting. Chen X, Tang J, White PF, Wender RH, Quon R, Sloninsky A, Naruse R, Kariger R, Webb T, Norel E. Anesth Analg; 2001 Oct; 93(4):906-11. PubMed ID: 11574355 [Abstract] [Full Text] [Related]
6. Antiemetic prophylaxis for office-based surgery: are the 5-HT3 receptor antagonists beneficial? Tang J, Chen X, White PF, Wender RH, Ma H, Sloninsky A, Naruse R, Kariger R, Webb T, Zaentz A. Anesthesiology; 2003 Feb; 98(2):293-8. PubMed ID: 12552184 [Abstract] [Full Text] [Related]
7. Dolasetron decreases postoperative nausea and vomiting after breast surgery. Abou Zeid H, Al-Gahamdi A, Abdul-Hadi M. Breast J; 2002 Feb; 8(4):216-21. PubMed ID: 12100113 [Abstract] [Full Text] [Related]
8. The effect of preoperative dexamethasone on the immediate and delayed postoperative morbidity in children undergoing adenotonsillectomy. Pappas AL, Sukhani R, Hotaling AJ, Mikat-Stevens M, Javorski JJ, Donzelli J, Shenoy K. Anesth Analg; 1998 Jul; 87(1):57-61. PubMed ID: 9661546 [Abstract] [Full Text] [Related]
9. Phase III double-blind comparison of dolasetron mesylate and ondansetron and an evaluation of the additive role of dexamethasone in the prevention of acute and delayed nausea and vomiting due to moderately emetogenic chemotherapy. Lofters WS, Pater JL, Zee B, Dempsey E, Walde D, Moquin JP, Wilson K, Hoskins P, Guevin RM, Verma S, Navari R, Krook JE, Hainsworth J, Palmer M, Chin C. J Clin Oncol; 1997 Aug; 15(8):2966-73. PubMed ID: 9256141 [Abstract] [Full Text] [Related]
10. Intravenous dolasetron and ondansetron in prevention of postoperative nausea and vomiting: a multicenter, double-blind, placebo-controlled study. Korttila K, Clergue F, Leeser J, Feiss P, Olthoff D, Payeur-Michel C, Wessel P, Nave S, Hahne W, Brown R. Acta Anaesthesiol Scand; 1997 Aug; 41(7):914-22. PubMed ID: 9265937 [Abstract] [Full Text] [Related]
11. A comparison of the costs and efficacy of ondansetron and dolasetron in the prophylaxis of postoperative vomiting in pediatric patients undergoing ambulatory surgery. Olutoye O, Jantzen EC, Alexis R, Rajchert D, Schreiner MS, Watcha MF. Anesth Analg; 2003 Aug; 97(2):390-396. PubMed ID: 12873923 [Abstract] [Full Text] [Related]
12. Double-blind, randomized comparison of the antiemetic efficacy of intravenous dolasetron mesylate and intravenous ondansetron in the prevention of acute cisplatin-induced emesis in patients with cancer. Dolasetron Comparative Chemotherapy-induced Emesis Prevention Group. Hesketh P, Navari R, Grote T, Gralla R, Hainsworth J, Kris M, Anthony L, Khojasteh A, Tapazoglou E, Benedict C, Hahne W. J Clin Oncol; 1996 Aug; 14(8):2242-9. PubMed ID: 8708713 [Abstract] [Full Text] [Related]
13. Preoperative oral ondansetron for pediatric tonsillectomy. Rose JB, Brenn BR, Corddry DH, Thomas PC. Anesth Analg; 1996 Mar; 82(3):558-62. PubMed ID: 8623961 [Abstract] [Full Text] [Related]
15. Ondansetron versus dolasetron: a comparison study in the prevention of postoperative nausea and vomiting in patients undergoing gynecological procedures. Browning BA, Fort CA, Kemp KD, Shimata MF, Strube MD. AANA J; 2004 Apr; 72(2):129-32. PubMed ID: 15098526 [Abstract] [Full Text] [Related]
16. [Prophylaxis of nausea and vomiting after thyroid surgery: comparison of oral and intravenous dolasetron with intravenous droperidol and placebo]. Danner K, Becker HG, Best B, Madler C. Anasthesiol Intensivmed Notfallmed Schmerzther; 2001 Jul; 36(7):425-30. PubMed ID: 11496617 [Abstract] [Full Text] [Related]
17. Postoperative nausea and vomiting after surgery for prognathism: not only a question of patients' comfort. A placebo-controlled comparison of dolasetron and droperidol. Piper SN, Röhm K, Boldt J, Kranke P, Maleck W, Seifert R, Suttner S. J Craniomaxillofac Surg; 2008 Apr; 36(3):173-179. PubMed ID: 18353666 [Abstract] [Full Text] [Related]
18. The efficacy and cost-effectiveness of prophylactic 5-hydroxytryptamine3 receptor antagonists: tropisetron, ondansetron and dolasetron. Paech MJ, Rucklidge MW, Banks SL, Gurrin LC, Orlikowski CE, Pavy TJ. Anaesth Intensive Care; 2003 Feb; 31(1):11-7. PubMed ID: 12635388 [Abstract] [Full Text] [Related]
19. Oral dolasetron mesylate for prevention of postoperative nausea and vomiting: a multicenter, double-blind, placebo-controlled study. The Oral Dolasetron PONV Prevention Study Group. Diemunsch P, Korttila K, Leeser J, Helmers JH, Wilkey B, Navé S, Radke AJ, Hahne WF, Brown RA. J Clin Anesth; 1998 Mar; 10(2):145-52. PubMed ID: 9524901 [Abstract] [Full Text] [Related]
20. A comparison of the efficacy, safety, and patient satisfaction of ondansetron versus droperidol as antiemetics for elective outpatient surgical procedures. S3A-409 and S3A-410 Study Groups. Fortney JT, Gan TJ, Graczyk S, Wetchler B, Melson T, Khalil S, McKenzie R, Parrillo S, Glass PS, Moote C, Wermeling D, Parasuraman TV, Duncan B, Creed MR. Anesth Analg; 1998 Apr; 86(4):731-8. PubMed ID: 9539593 [Abstract] [Full Text] [Related] Page: [Next] [New Search]